TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$160.97M2017: -$253.84M2018: -$290.57M2019: -$345.38M2020: -$132.22M2021: -$338.69M2022: -$380.46M2023: -$475.00M2024: -$414.00M2025: -$466.00M-$466.00M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$466.00M-12.6%
2024-$414.00M+12.8%
2023-$475.00M-24.8%
2022-$380.46M-12.3%
2021-$338.69M-156.2%
2020-$132.22M+61.7%
2019-$345.38M-18.9%
2018-$290.57M-14.5%
2017-$253.84M-57.7%
2016-$160.97M—